Aptevo expands cancer pipeline with two new trispecific therapies
Aptevo has announced the expansion of its cancer treatment pipeline with two new trispecific therapies. This development aims to enhance treatment options for patients battling cancer.
WPN Brief
Aptevo has announced the expansion of its cancer treatment pipeline with two new trispecific therapies. This development aims to enhance treatment options for patients battling cancer.
Ask WPN AI